CD34+ BM cells derived from CML patients secreted up to 10 times more VEGF, FGF-b, HGF, and IL-8 compared to normal donors' BM CD34+ cells. Here, FGF2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.